Drug Trial Radar · NCT07284589
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Last checked: Nov 20, 2026Latest source record: Apr 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Dec 11, 2025
Primary completion
Apr 30, 2030
Study completion Apr 30, 2030
Sponsor
- Lead sponsor
- Akiva MintzAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 16, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 120 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to evaluate an investigational ultralow dose positron emission tomography (PET) imaging technique for neuroendocrine tumor detection and monitoring. The main question it aims to answer is: Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold of the current clinical standard? Participants will be injected with a radioactive tracer that binds to a tumor specific protein called somatostatin receptor 2 (SSTR2) and be imaged on a new type of high sensitivity PET scanner for up to 3 hours
Conditions
- Healthy (Controls)
- Healthy Volunteers
- Neuroendocrine (NE) Tumors
Interventions
68Ga-DotatateDrug
Participants will be injected with 68Ga-DOTATATE and imaged for up to 3 hours on a PET scanner
Primary outcomes
What the sponsor says the trial is designed to measure.
- Signal-to-Noise Ratio (SNR)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Contrast-to-Noise Ratio (CNR)Time frame: Time Frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Coefficient of Variation (COV)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Spatial Resolution (Full Width at Half Maximum - FWHM)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Target-to-Background Ratio (TBR)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Qualitative Image Quality Score (Likert Scale)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
- Inter-reader Agreement (Weighted Kappa Statistics)Time frame: Evaluated annually (once per year), based on pooled images acquired during the preceding 12-month period.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nuclear Imaging Institute
Englewood, New Jersey · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.